Alpha Signal Monitor - Daily Market Briefing | November 24, 2025
Daily Market Research Report
November 24, 2025
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Gold ETF Outlook — week of 2025-11-24
Trading Idea: Buy Rationale (TL;DR): Most top-tier houses (GS, JPM, BofA, HSBC, UBS, MS, DB) maintain bullish end-2025 to 2026 gold targets on strong central-bank and ETF demand plus an expected Fed easing cycle—supporting long exposure via GLD/IAU/BAR.
Policy uncertainty (tariffs, fiscal deficits, and Fed path), ongoing geopolitics, and still-elevated real policy rates shifting lower underpin strategic demand for gold; banks now see 2025 averages broadly in the $3.3–3.7k/oz range and 2026 paths toward $4–5k/oz.
Key Drivers - Central bank buying projected around 900–1,000t in 2025, alongside a structural rise in strategic allocations. - ETF inflows expected to persist as rates decline and portfolio hedging demand stays elevated. - Easing cycle from the Fed and potential USD softness reduce gold’s opportunity cost. - Trade/tariff and geopolitical risks keep safe‑haven bids firm. - Large fiscal deficits and concerns over Fed independence amplify debasement/insurance demand.
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Overweight/Bullish | $3,100/oz by end‑2025 (prior); path to ~$4,000/oz by mid‑2026; upside tail risk toward ~$5,000/oz if Fed independence compromised. | Drivers: robust central‑bank demand, revival of ETF demand as rates fall; structural buyers support new highs; tail‑risk scenario tied to loss of Fed independence. | 2025-09-30 | - |
| Morgan Stanley | Positive/Constructive | Sees potential to ~$4,500/oz by mid‑2026; notes jewelry demand softness and positioning risks near‑term. | Expect continued ETF and central‑bank buying as rates decline; recent correction seen as healthy clean‑up of positioning. | 2025-10-31 | - |
| JP Morgan | Overweight/Top conviction | Avg ~$3,675/oz by Q4‑2025; ~ $4,000/oz by mid‑2026; later update projects ~$5,055/oz average by Q4‑2026. | Structural bull case on strong CB + investor demand; gold as optimal hedge for stagflation/recession/debasement/U.S. policy risks. | 2025-10-23 | - |
| Bank of America | Bullish | Lifts 2026 target to $5,000/oz (avg ~$4,400); supportive 2025 backdrop with correction risk near‑term. | Sees investment demand up ~14% y/y in 2026 sustaining rally; tariffs, deficits, and rate cuts supportive. | 2025-10-13 | - |
| Citigroup | Tactical Neutral; Structural Positive | Cut 0–3m target to ~$3,800/oz (2025‑10‑28); earlier 3m raised to $3,500 (2025‑04‑17); 6–12m guidance biased to consolidation. | Short‑term moderation as momentum cools and uncertainty eases; still sees medium‑term allocation case amid policy/geopolitical risks. | 2025-10-28 | - |
| UBS | Attractive/Overweight | Raised base case to $3,500/oz across tenors (Apr‑2025); sees 2025 CB buying near 1,000t; upside to ~$3,800 and potentially higher if real rates decline. | Structural increase in allocations (CBs, Asia insurers), ETF net buying resuming; continued policy/geopolitical hedging demand. | 2025-04-11 | - |
| HSBC | Positive | Raised 2025 average to ~$3,455/oz; 2026 average to ~$4,600/oz; scenario sees ~$5,000/oz by 1H‑2026. | Safe‑haven and diversification demand; warns rallies can moderate if USD strengthens or rate cuts underwhelm. | 2025-10-17 | - |
| Deutsche Bank | Positive | 2025 average ~$3,139/oz (Q4‑2025 ~$3,350); 2026 average lifted to ~$4,000/oz; sees upside on CB demand and easing cycle. | Raised forecasts on robust official demand, potential USD weakness, and Fed easing; flags Fed‑independence concerns as supportive. | 2025-09-17 | - |
Risk Considerations - Fewer/faster‑reversing Fed cuts or renewed USD strength could cap or reverse gains. - A sharp fade in ETF or official‑sector demand (e.g., if prices remain very elevated) would weaken the thesis. - Geopolitical de‑escalation and stronger global growth could shift flows back to risk assets. - Short‑term overbought conditions raise correction/volatility risk.
Consensus skew remains higher into 2026 with most houses targeting $4k–$5k/oz as base/average paths; continue accumulating on dips via low‑cost physical‑backed ETFs (GLD/IAU/BAR), scaling risk for near‑term volatility and USD surprises.
Stock Ratings — U.S. Mega-Cap Tech: Street Targets and Ratings from GS/MS/JPM/BofA/Citi/Wells (as of 2025-11-24)
We compiled the latest publicly available target prices, ratings, and note dates from the six requested institutions for each ticker. Where no recent, citable update could be found, fields are set to null. Source pages used: MarketBeat forecast pages for each ticker. Citations: AAPL, MSFT, AMZN, NVDA, META, TSLA, AVGO, GOOGL, TSM.
AAPL - Apple Inc.
Late-October cluster of hikes across the six: GS to 320, MS to 305, JPM to 305, BofA to 320, Citi to 315, WFC to 300; tone is broadly positive (Buy/Overweight).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $320 | 2025-10-31 | Boosted target ($279 → $320). | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Morgan Stanley | Overweight | $305 | 2025-10-29 | Boosted target ($298 → $305). | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| JP Morgan | Overweight | $305 | 2025-10-31 | Boosted target ($290 → $305). | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Bank of America | Buy | $320 | 2025-10-27 | Boosted target ($270 → $320). | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Citigroup | Buy | $315 | 2025-10-31 | Reiterated Buy; raised target ($245 → $315). | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Wells Fargo | Overweight | $300 | 2025-10-31 | Set target ($290 → $300). | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
Consensus View - Rating: Buy, Target Price: $310.8 - Strong alignment; all six at Buy/Overweight with average TP ≈ $311.
MSFT - Microsoft Corp.
MS, WFC, Citi raised targets into late Oct; GS reiterated Buy. JPM reiterated Buy on 2025-11-18 without a public TP on the feed.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $630 | 2025-10-27 | Reiterated Buy. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Morgan Stanley | Overweight | $650 | 2025-10-30 | Raised target ($625 → $650). | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| JP Morgan | Buy | - | 2025-11-18 | Reiterated Buy (target not shown on public snippet). | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Bank of America | Buy | $640 | 2025-07-24 | Raised target ($585 → $640). | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Citigroup | Buy | $690 | 2025-10-30 | Raised target ($682 → $690). | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Wells Fargo | Overweight | $700 | 2025-10-30 | Raised target ($675 → $700). | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
Consensus View - Rating: Buy, Target Price: $662.0 - 5 stated TPs average ≈ $662; ratings skew Buy/Overweight.
GOOGL - Alphabet Inc.
Multiple 2025-10-30 boosts: GS to 330, MS to 330, BofA to 335; WFC Equal Weight at 268. Citi/JPM not visible in the recent table snapshot.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $330 | 2025-10-30 | Raised target ($288 → $330). | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Morgan Stanley | Overweight | $330 | 2025-10-30 | Raised target ($270 → $330). | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Bank of America | Buy | $335 | 2025-10-30 | Raised target ($280 → $335). | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Wells Fargo | Equal Weight | $268 | 2025-10-30 | Raised target ($236 → $268). | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
Consensus View - Rating: Buy, Target Price: $315.8 - Based on 4 stated TPs; skewed to Buy with one Hold-equivalent.
AMZN - Amazon.com Inc.
Street-wide target lifts on 2025-10-31: MS 315, JPM 305, BofA 303, Citi 320, WFC 292; GS earlier to 275.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $275 | 2025-09-30 | Raised target ($240 → $275). | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Morgan Stanley | Overweight | $315 | 2025-10-31 | Raised target ($300 → $315). | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| JP Morgan | Overweight | $305 | 2025-10-31 | Raised target ($265 → $305). | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Bank of America | Buy | $303 | 2025-10-31 | Raised target ($272 → $303). | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Citigroup | Buy | $320 | 2025-10-31 | Raised target ($270 → $320). | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Wells Fargo | Overweight | $292 | 2025-10-31 | Raised target ($280 → $292). | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
Consensus View - Rating: Buy, Target Price: $301.7 - All six at Buy/Overweight; average TP ≈ $302.
NVDA - NVIDIA Corp.
Post-earnings flurry of raises in mid-late Nov/Oct: MS 235, JPM 250, BofA 275, WFC 265; GS to 240; Citi to 270.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $240 | 2025-10-30 | Raised target ($210 → $240). | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Morgan Stanley | Overweight | $235 | 2025-11-20 | Raised target ($220 → $235). | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| JP Morgan | Overweight | $250 | 2025-11-18 | Raised target ($215 → $250). | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Bank of America | Buy | $275 | 2025-10-22 | Raised target ($235 → $275). | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Citigroup | Buy | $270 | 2025-11-20 | Raised target ($220 → $270). | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Wells Fargo | Overweight | $265 | 2025-11-13 | Raised target ($220 → $265). | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
Consensus View - Rating: Buy, Target Price: $255.8 - Consensus firmly Buy; average of six TPs ≈ $256.
META - Meta Platforms Inc.
After 2025-10-30 earnings: JPM to 800, BofA to 810, Citi to 850, WFC to 802; MS lifted earlier to 850; GS reiterated Buy without publicly visible TP.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2025-08-05 | Reiterated Buy; TP not shown on public snippet. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Morgan Stanley | Overweight | $850 | 2025-07-31 | Raised target ($750 → $850). | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| JP Morgan | Overweight | $800 | 2025-10-30 | Lowered target ($875 → $800). | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Bank of America | Buy | $810 | 2025-10-30 | Lowered target ($900 → $810). | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Citigroup | Buy | $850 | 2025-10-30 | Lowered target ($915 → $850). | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Wells Fargo | Overweight | $802 | 2025-10-30 | Lowered target ($837 → $802). | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
Consensus View - Rating: Buy, Target Price: $822.4 - Five stated TPs average ≈ $822; overall Buy/Overweight tilt.
TSLA - Tesla Inc.
Mixed views: GS cut to 400 (Neutral); BofA raised to 471 (Neutral); WFC remains Underweight at 130 (2024-11); MS reiterated Overweight; JPM lifted TP to 150 (rating not shown).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Neutral | $400 | 2025-10-23 | Cut target ($425 → $400). | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Morgan Stanley | Overweight | - | 2025-10-13 | Reiterated Overweight; TP not shown on public snippet. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| JP Morgan | - | $150 | 2025-09-22 | Raised target ($115 → $150); rating not shown. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Bank of America | Neutral | $471 | 2025-10-24 | Raised target ($341 → $471). | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Wells Fargo | Underweight | $130 | 2024-11-14 | Lowered target ($135 → $130). | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
Consensus View - Rating: Hold, Target Price: $287.8 - Average of four stated TPs ≈ $288; ratings mix skews to Hold overall.
AVGO - Broadcom Inc.
September–October wave of higher targets: JPM 400, BofA 400, Citi 415, MS 409; WFC Equal Weight 345; GS reiterated Buy 340.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $340 | 2025-07-28 | Reiterated Buy. | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Morgan Stanley | Overweight | $409 | 2025-10-14 | Set target ($382 → $409). | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| JP Morgan | Overweight | $400 | 2025-09-05 | Raised target ($325 → $400). | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Bank of America | Buy | $400 | 2025-09-05 | Raised target ($300 → $400). | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Citigroup | Buy | $415 | 2025-10-14 | Reiterated Buy; raised target ($350 → $415). | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Wells Fargo | Equal Weight | $345 | 2025-09-05 | Raised target ($255 → $345). | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
Consensus View - Rating: Buy, Target Price: $384.8 - Average of six TPs ≈ $385; mostly Buy/Overweight with one Hold-equivalent.
TSM - Taiwan Semiconductor Manufacturing Co. Ltd.
Could not locate recent, citable bank-specific targets from the six requested U.S. institutions on public pages; coverage in the last 90 days on MarketBeat shows other brokers.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Morgan Stanley | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| JP Morgan | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Bank of America | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Citigroup | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Wells Fargo | - | - | - | - | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
Consensus View - No recent entries from the specified six banks visible on the public aggregator.
Highlights
- AAPL: All six banks positive; average target ≈ $311 after a cluster of 2025-10 updates.
- MSFT: WFC to $700 and MS to $650 on 2025-10-30; Citi to $690.
- AMZN: Broad-based raises on 2025-10-31; Citi to $320, MS to $315, JPM to $305.
- NVDA: JPM to $250 (2025-11-18), MS to $235 (2025-11-20), BofA to $275 (2025-10-22).
- META: JPM to $800, BofA to $810, Citi to $850, WFC to $802 on 2025-10-30.
- TSLA: Mixed—BofA $471 (Neutral), GS $400 (Neutral), WFC $130 (Underweight), MS Overweight (TP not shown), JPM TP $150.
- AVGO: JPM and BofA each to $400; Citi to $415; MS to $409 (Oct).
Notes: Ratings terminology mapped to Buy/Hold/Sell where possible (e.g., Overweight=Buy, Equal Weight=Hold, Underweight=Sell). Consensus target is the average of available targets from the six named institutions only; entries with null targets are excluded from the average. If you’d like this exported to CSV or want me to fill in missing items (e.g., older JPM/Citi notes on GOOGL or TSM) with additional sources, I can extend the search.
IPO Calendar
Timeframe: December 1–31, 2025 (US equity markets)
As of November 24, 2025, no major US exchanges have posted firm December pricing dates yet; that is typical because IPO dates are rarely set more than 7–10 days in advance. Activity is expected to concentrate in the two trading weeks starting December 8 and December 15, the remaining window most issuers target before year‑end. Notable themes for the month include: (i) cross‑border consumer/tech listings (PayPay; Klook) looking to tap deep US liquidity; (ii) space and defense hardware (York Space Systems) leveraging investor interest in national security and LEO satellite constellations; and (iii) very large private‑equity‑backed issuers (Medline) that are on file and could move quickly if market conditions allow, though timing may slip into early 2026.
PayPay Corporation
- Expected listing date: December 2025 (as early as December; exact date TBA)
- Business summary: Japan’s leading QR‑code payments app operator backed by SoftBank; the business also offers banking and credit card services and is beginning to enable international payments, positioning it for growth beyond Japan.
- Notes: Reuters reports SoftBank has been meeting investors and that a baseline valuation of ~¥2T could exceed ¥3T (~$20B); timing remains dependent on market conditions and final SEC clearance. Exchange, ticker, shares and price range have not been announced.
- Sources: Reuters (Oct 14, 2025): PayPay valuation could exceed $20B in planned December U.S. IPO, Financial Times (Aug 2025): SoftBank-owned PayPay files for U.S. listing
York Space Systems, Inc. (YSS)
- Expected listing date: December 2025 (TBA; issuer filed S‑1 on Nov 17, 2025)
- Exchange: NYSE
- Lead underwriters: Goldman Sachs & Co. LLC, Jefferies, Wells Fargo Securities
- Business summary: US small‑satellite manufacturer focused on modular spacecraft for defense and commercial constellations; significant exposure to the Space Development Agency’s Proliferated Warfighter Space Architecture (PWSA). 9M25 revenue $280.9m (+59% y/y); 2024 revenue $253.5m.
- Notes: Filed a Form S‑1 on Nov 17, 2025 and intends to list as “YSS” on the NYSE. Launch timing is subject to market window and SEC review; Reuters notes most December activity is likely during the weeks of Dec 8 and Dec 15. No price range or share count has been set yet.
- Sources: SEC Form S‑1 (Nov 17, 2025) — York Space Systems, Business Wire (Nov 17, 2025): York files S‑1 for proposed IPO, Reuters (Nov 17, 2025): York Space Systems files for US IPO; revenue up 59%
Klook Technology Limited (KLK)
- Expected listing date: December 2025 (TBA; filed Nov 10, 2025)
- Exchange: NYSE
- Lead underwriters: Goldman Sachs (Asia) L.L.C., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC
- Business summary: APAC‑focused online travel experiences marketplace (tours, attractions, transport) backed by SoftBank; reported 2024 revenue of $417.1m (+24% y/y).
- Notes: Filed a Form F‑1 on Nov 10, 2025; company has applied to list ADSs on NYSE as “KLK.” The offering size has not been set publicly (media reporting indicates a potential $300–$500m raise). Timing depends on SEC effectiveness and market conditions.
- Sources: Company press release (Nov 10, 2025): Klook files F‑1; applies to list as KLK (NYSE), Reuters (Nov 10, 2025): Klook makes US IPO filing public; 2024 revenue +24%, Bloomberg (Nov 10, 2025): Klook files for New York IPO, aiming $300m–$500m
Medline Industries, Inc. (MDLN)
- Expected listing date: Late 2025 or early 2026 (TBA)
- Exchange: Nasdaq
- Lead underwriters: Goldman Sachs, Morgan Stanley, BofA Securities, J.P. Morgan
- Business summary: One of the world’s largest manufacturers and distributors of medical supplies to hospitals and healthcare providers; H1’25 net sales $13.53bn (+9.7% y/y) and $655m profit. Private‑equity owned (Blackstone, Carlyle, Hellman & Friedman).
- Notes: Public filing made Oct 28, 2025; underwriters and proposed ticker “MDLN” disclosed. Board is weighing timing and could list before year‑end or slip to early 2026 depending on conditions; no launch date, range, or shares disclosed yet.
- Sources: Reuters (Oct 28, 2025): Medline reveals public IPO filing; aims to list as MDLN on Nasdaq, Financial Times (Sept 2025): Medline weighing late‑2025 vs early‑2026 timing
This calendar reflects deals that are either publicly filed and signaling a December window or reported by credible outlets as targeting December. Micro‑cap IPOs and SPAC IPOs may be announced on shorter notice and are not fully captured here. All terms (dates, share counts, ranges, exchanges, tickers) remain subject to SEC review, market conditions, and issuer decisions; many syndicates do not set terms until 7–10 days before pricing.
Sources
- Stock Ratings: https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/, https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/META/forecast/, https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/, https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/, https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/, https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2025-11-24 at 11:18 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI